Abstract:Objective To investigate the changes in levels of microRNA-374 a-5 p (miR-374 a-5 p) and IL-10 in the peripheral blood of patients with deep venous thrombosis (DVT) and to explore the relationship between them. Methods Thirty cases of DVT patients (DVT group) and 30 cases of healthy people (healthy control group) were selected. The serum and peripheral blood mononuclear cells (PBMCs) from the fasting venous blood of all subjects were isolated. The expression of IL-10 in serum was detected by ELISA and miR-374 a-5 p was detected by q PCR. Target Scan 7.1 software was used to predict the binding site between miR-374 a-5 p and IL-10; besides, 3'UTR luciferase reporter assay was used to confirm the binding between them. The 293 T cells were divided into the intervention group and control group, and cells in the intervention group were transfected with miR-374 a-5 p mimics and wide-type or mutant IL-10 mRNA 3'UTR fluorescent reporter gene pmir GLO vector, respectively. Luciferase reporter gene activity was detected by using dual luciferase reportergene system. In addition, 293 T cells were divided into 3 groups. The cells in the overexpression group and the inhibition group were transfected with miR-374 a-5 p mimics and inhibitor by using Lipofectamine 2000, respectively, and the cells in the blank control group were transfected with negative control primers. The cells were harvested 24 h after transfection.Then, the expression of IL-10 mRNA was detected by q PCR, and the protein level of IL-10 was detected by ELISA. Results Compared with the healthy control group, the serum IL-10 protein level decreased while the miR-374 a-5 p expression in the PBMCs increased significantly in the DVT group (both P < 0.05). Target Scan 7.1 and luciferase reporter assay showed that miR-374 a-5 p bound to IL-10 3'UTR via the complementary bases. The dual luciferase reporter gene system assay showed that the activity of the wild-type IL-10 mRNA 3'UTR luciferase reporter gene decreased in the intervention group as compared with that of the control group (P < 0.05) , but the mutant IL-10 mRNA 3'UTR did not change significantly (P> 0.05). Compared with the blank control group, IL-10 mRNA expression and IL-10 protein decreased in the overexpression group (both P < 0.05) , while increased in the inhibition group (both P < 0.05). Conclusions Serum IL-10 decreases while miR-374 a-5 p increases in the PBMCs of DVT patients. The miR-374 a-5 p inhibits the expression of IL-10 by binding to IL-10 3'UTR. Thereby, the mediated inflammation is involved in DVT. The miR-374 a-5 p may become a novel therapeutic target for DVT by regulating IL-10.

MiR-128-3p promotes the progression of deep venous thrombosis through binding SIRT1

Upregulation of Mir-483-3p Contributes to Endothelial Progenitor Cells Dysfunction in Deep Vein Thrombosis Patients Via SRF.

miR-374b-5p is increased in deep vein thrombosis and negatively targets IL-10

Increased miR-6132 promotes deep vein thrombosis formation by downregulating FOXP3 expression

Role and Mechanism of Mir-5189-3p in Deep Vein Thrombosis of Lower Extremities

MiR-132-3p regulates proliferation of endothelial progenitor cells mediated by FOXO1

Downregulation of Interleukin-6 and C-reactive Protein Underlies a Novel Inhibitory Role of Microrna-136-5p in Acute Lower Extremity Deep Vein Thrombosis

Changes in Levels of Mir-374A-5p and IL-10 in Peripheral Blood of DVT Patients and the Relationship Between Them

Advances in microRNA regulation of deep vein thrombosis through venous vascular endothelial cells (Review)

Mir-21 Induces Endothelial Progenitor Cells Proliferation and Angiogenesis Via Targeting FASLG and is a Potential Prognostic Marker in Deep Venous Thrombosis

miR-10b-5p regulates venous endothelial cells in deep venous thrombosis by targeting MFG-E8

Upregulation of Microrna-126 Contributes to Endothelial Progenitor Cell Function in Deep Vein Thrombosis Via Its Target Pik3r2

Downregulation of Mir-125A-5p Promotes Endothelial Progenitor Cell Migration and Angiogenesis and Alleviates Deep Vein Thrombosis in Mice Via Upregulation of MCL-1.

Hsa_circ_0001020 accelerates the lower extremity deep vein thrombosis via sponging miR-29c-3p to promote MDM2 expression

MiR-497-5p Ameliorates Deep Venous Thrombosis by Facilitating Endothelial Progenitor Cell Migration and Angiogenesis by Regulating LITAF

miRNA-130 Promotes Migration and Angiogenesis of Endothelial Progenitor Cells Through PI3K/AKT/mTOR Pathways

Up-regulated miR-204-5p promoted the migration, invasion, and angiogenesis of endothelial progenitor cells to enhance the thrombolysis of rats with deep venous thrombosis by targeting SPRED1

Role of Microrna-26A in the Diagnosis of Lower Extremity Deep Vein Thrombosis in Patients with Bone Trauma

miR-483-5p-Containing exosomes treatment ameliorated deep vein thrombosis‑induced inflammatory response

Combination of Circulating miR-125a-5p, miR-223-3p and D-dimer as a Novel Biomarker for Deep Vein Thrombosis

IL (Interleukin)-6 Contributes to Deep Vein Thrombosis and is Negatively Regulated by Mir-338-5p